ZnS@BSA Nanoclusters Potentiate Efficacy of Cancer Immunotherapy

Adv Mater. 2021 Dec;33(49):e2104037. doi: 10.1002/adma.202104037. Epub 2021 Oct 7.

Abstract

Although immunotherapy such as immune checkpoint inhibitors has shown promising efficacy in cancer treatment, the responsiveness among patients is relatively limited. Activation of the cyclic guanosine monophosphate-adenosine monophosphate synthase/interferon gene stimulator (cGAS/STING) signaling pathway to upregulate innate immunity has become an emerging strategy for enhancing tumor immunotherapy. Herein, ZnS@BSA (bovine serum albumin) nanoclusters synthesized via a self-assembly approach are reported, where the released zinc ions under acidic tumor microenvironment significantly enhance cGAS/STING signals. Meanwhile, intracellular zinc ions can produce reactive oxygen species, which is further facilitated by the generated H2 S gas from ZnS@BSA via specifically inhibiting catalase in hepatocellular carcinoma cells. It is found that the nanoclusters activate the cGAS/STING signals in mice, which promotes the infiltration of CD8+ T cells at the tumor site and cross-presentation of dendritic cells, leading to an improved immunotherapy efficacy against hepatocellular carcinoma.

Keywords: cGAS/STING; cancer immunotherapy; drug delivery; hepatocellular carcinoma; nanomedicine.

MeSH terms

  • Animals
  • CD8-Positive T-Lymphocytes
  • Carcinoma, Hepatocellular* / therapy
  • Humans
  • Immunotherapy
  • Liver Neoplasms* / therapy
  • Membrane Proteins / metabolism
  • Metal Nanoparticles
  • Mice
  • Nucleotidyltransferases / genetics
  • Nucleotidyltransferases / metabolism
  • Sulfides
  • Tumor Microenvironment
  • Zinc Compounds* / pharmacology

Substances

  • Membrane Proteins
  • Sulfides
  • Zinc Compounds
  • Nucleotidyltransferases
  • zinc sulfide